OP
Optimi Health Corp.
OPTH · NASDAQ
$4.95 -0.80% (-$0.04)
1M -0.60%
Market Cap $15.9M
P/E Ratio -
Div. Yield -
ROE 89.86%
Bulios Fair Price
$7.03
42.0% upside
Current Price
$4.95
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OPTH is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/B 1.28x
P/S 118.81x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 25.67%
Rev. growth 74.23%
FCF growth N/A
Profitability
0 /100
Weak Net margin 4,611.03%
Op. margin 4,327.70%
FCF margin 3,323.10%
Quality
0 /100
Poor ROE 89.86%
ROA 33.98%
Asset turnover 0.01x
Debt
66 /100
Moderate Current ratio 1.73x
Int. coverage -5.81x
Debt/Equity 0.29x
Stability
27 /100
Unstable Rev. volatility 63.85%
EPS volatility 30.42%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OPTH
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dane Stevens
Employees
6
Headquarters
Princeton
Upcoming events
02 FEB
Earnings
Upcoming earnings report